Triflubazam

Drugbox
IUPAC_name = 5-methyl-1-phenyl-8-(trifluoromethyl)-1,5-benzodiazepine-2,4-dione

---

width=180
CAS_number=22365-40-8
ATC_prefix=
ATC_suffix=
ATC_supplemental=
PubChem=31157
DrugBank=
C=17 | H=13 | F=3 | N=2 | O=2
molecular_weight = 334.29
bioavailability=
metabolism =
elimination_half-life=
excretion =
pregnancy_category =
legal_status =
routes_of_administration=

Triflubazam is a drug which is a 1,5-benzodiazepine derivative, related to clobazam. It has sedative and anxiolytic effects, with a long half-life and duration of action. [Itil TM, Akpinar S, Fink M: Controlled clinical and quantitative EEG studies of triflubazam (ORF 8063) in patients with anxiety syndrome. "Current Therapeutic Research" 1976; 19: 307-315] [Csanalosi I, Pereira-Oran J, Case G, et al: Triflubazam (ORF 8063), a new benzodiazepine in anxiety neurosis. "Current Therapeutic Research" 1977; 22: 166-171] [Nicholson AN, Stone BM, Clarke CH. Effect of the 1,5-benzodiazepines, clobazam and triflubazam, on sleep in man. "British Journal of Clinical Pharmacology". 1977 Oct;4(5):567-72.]

References

[http://www.psychotropics.dk/usr_view_molecule.asp?ID=1451&backurl=Codeindex%2Fview%5FCodes%2Easp%3FStartchar%3DC&backurlname=Code+numbers&Catalogtype=A&historyline=]